Acute Manifestations of Systemic Lupus Erythematosus

  • Melinda McVicar
Part of the Developments in Nephrology book series (DINE, volume 7)


The diagnosis of systemic lupus erythematosus (SLE) rests on clinical criteria prosposed by the American Rheumatism Association. These have recently been revised to incorporate several serologic criteria and the revision (Table 1) is currently in press (1). Any four of the cited 11 manifestations in any sequence of time constitutes the diagnosis of SLE.


Systemic Lupus Erythematosus Acute Renal Failure Lupus Nephritis Pulmonary Hemorrhage Cortical Atrophy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Rothfield, N.F.: DM Disease a Month: 29 : 46 , 1982 (Oct).Google Scholar
  2. 2.
    Piatt, J.L., Burke, B.A., Fish, A.J., Kim, Y., & Michael, A.F.:Systemic Lupus Erythematosus in the First Two Decades of Life. Am. J. of Kid. Dis. Suppl. 11: 212, 1982.Google Scholar
  3. 3.
    Estes, D. & Christian, C.: The natural history of SLE by prospective analysis. Medicine 50: 85, 1971.PubMedCrossRefGoogle Scholar
  4. 4.
    Adu, D., and Cameron, J.S.: Lupus Nephritis. Clinics in Rheumatic Diseases 8:153,1982 (April).PubMedGoogle Scholar
  5. 5.
    Ponticelli, C., Imbasciati, E., Brancaccio, D., Tarantino, A., & Rivolta, E.: Acute renal failure in systemic lupus erythematosus, British Medical Journal iii: 716, 1974.CrossRefGoogle Scholar
  6. 6.
    Baldwin, D.S., Gluck, M.C., Lowenstein, J., & Gallo, G.R.: Lupus nephritis. Clinical course as related to morphologic forms and their transitions. American Journal of Medicine 62: 12, 1977.PubMedCrossRefGoogle Scholar
  7. 7.
    Pollak, V.E., & Dosekun,A.K.: Evaluation of treatment in Lupus Nephritis: Effects of Prednisone. Am. J. of Kid. Dis. Suppl. 11: 170, 1982.Google Scholar
  8. 8.
    Pohl, M.A., Krakauer, R., Gephardt, G., Hunsicker, L., Roberts, J.L., Schwartz, M.M., & Lewis, E.J.: Modified Criteria for the Diagnosis of Systemic Lupus Erythematosus in the Presence of Diffuse Proliferative Nephritis. Kid. Internat. 23: 131, 1983.Google Scholar
  9. 9.
    Pollak, V.E., Pirani, C.L., & Kark, R.M.: Effect of Large Doses of Prednisone on the Renal Lesions and Life Span of Patients with Lupus Glomerulonephritis. J. Lab. Clin. Med. 57: 495, 1961.PubMedGoogle Scholar
  10. 10.
    Hayslett, J.P., Kashgarian, M., & Cook, C.D., et al: The effect of azathioprine on lupus glomerulonephritis. Medicine 51: 393, 1972.PubMedCrossRefGoogle Scholar
  11. 11.
    Shelp, W.D., Bloodworth, J.M.B., Jr., & Rieselbach, R.E.: Effect of azathioprine on renal histology and function in lupus nephritis. Arch. Intern. Med. 128: 566, 1971.PubMedCrossRefGoogle Scholar
  12. 12.
    Decker, J.L., Steinberg, A.D., & Reinertsen, J.L., et al: Systemic lupus erythematosus: Evolving concepts. Ann. Intern. Med. 91: 587, 1979.PubMedGoogle Scholar
  13. 13.
    Donadio, J.V., Jr., Holley, K.E. & Ferguson, R.H., et al: Treatment of diffuse proliferative lupus nephritis with prednisone and combined prednisone and cyclophosphamide. N. Engl. J. Med. 299: 1151, 1978.PubMedCrossRefGoogle Scholar
  14. 14.
    Donadio, J.V., Jr., Holley, K.E., & Wagoner, R.D., et al: Treatment of lupus nephritis with prednisone and combined prednisone and azathioprine. Ann. Intern. Med. 77: 829, 1972.PubMedGoogle Scholar
  15. 15.
    Hahn, B.H., Kantor, O.S., & Osterlaxid, C.K.: Azathioprine plus prednisone compared with prednisone alone in the treatment of systemic lupus erythematosus: Report of a prospective controlled trial in 24 patients. Ann. Intern. Med. 83: 597, 1975.PubMedGoogle Scholar
  16. 16.
    Donadio, J.V., Jr., Holley, K.E., & Ilstrup, D.M.: Adrenocorticoid and cytotoxic drug treatment of lupus nephropathy. Proceedings of the 8th International Congress of Nephrology, Athens,Greece, pp. 643, 1981.Google Scholar
  17. 17.
    Kimberly, R.P., Lockshin, M.D., & Sherman, R.L., et al: High-dose intravenous methylprednisolone pulse therapy in systemic lupus erythematosus. Am. J. Med. 70: 817, 1981.PubMedCrossRefGoogle Scholar
  18. 18.
    Barron, KS, Person, DA, Brewer, EJ, Jr., Beale, MG, Robson, AM: Pulse methyIprednisolone therapy in diffuse proliferative lupus nephritis. J. pediatr. 101: 137, 1982.PubMedCrossRefGoogle Scholar
  19. 19.
    Jones, J.V., Cumming, R.H., & Bacon, P.A., et al: Evidence for a therapeutic effect of plasmapheresis in patients with systemic lupus erythematosus. O. J. Med. 48: 555, 1979.Google Scholar
  20. 20.
    Lockwood, C.M., Worlledge, S. & Nicholas, A., et al: Reversal of impaired splenic functions in patients with nephritis orvasculitis (or both) by plasma exchange. N.Engl. J. Med. 300: 524, 1979.Google Scholar
  21. 21.
    Jones, J.V., Robinson, M.F. & Parciany, R.K., et al: Therapeutic plasmapheresis in systemic lupus erythematosus: Effect on immune complexes and antibodies to DNA. Arth. Rheum. 24: 1113, 1981.CrossRefGoogle Scholar
  22. 22.
    Wei.,N, Huston, DP, Lawley, PJ, Steinberg, AD, Klippel, JH, Hall, RP, Balow, JE, Decker, JL: Randomized trial of plasma exchange in mild systemic lupus erythematosus. Lancet 1: 17, 1983.PubMedCrossRefGoogle Scholar
  23. 23.
    The Lupus Nephritis Study Group. Short-term Prognosis in Severe Lupus Nephritis. Kidney Internat. 23: 129, 1983.Google Scholar
  24. 23A.
    Leehey, D.J., Katz, A.I., Azaran, A.H., Aronson, A.J. & Spargo, B.H.: Silent diffuse lupus nephritis: Long-term follow-up. Am. J. Kidney Dis. Vol. 11, No. 1 Suppl. 1, July 1982.Google Scholar
  25. 24.
    Cohen, A.H., Wang, H., Border, W.A., & Glassock, R.J.: Acute renal failure due to acute tubular necrosis in lupus nephritis. Kidney Internat. 23: 119, 1983.Google Scholar
  26. 25.
    Dubois, E.L., & Tuffanelli, D.L.: Clinical Manifestations of Systemic Lupus Erythematosus. JAMA 190: 104, 1964.PubMedGoogle Scholar
  27. 26.
    Wallace, C., Schaller, J.G., Emery, H.M., & Wedgwood, R.: Prospective Study of Childhood Systemic Lupus Erythematosus (SLE). Arth. and Rheum. 21: 599, 1978.Google Scholar
  28. 27.
    Honig, S., Gorevic, P. & Weissman, G.: C-reactive protein in systemic lupus erythematosus. Arth. and Rheum. 20: 1065, 1977.CrossRefGoogle Scholar
  29. 28.
    Hill, A.G.S.: C-reactive protein in chronic rheumatic diseases. Lancet 1: 807, 1951.CrossRefGoogle Scholar
  30. 29.
    Zein, N., Ganuza, C. & Koshner, I.: Significance of serum C-reactive protein elevation in patients with systemic lupus erythematosus. Arthritis and Rheum. 22: 7, 1979.CrossRefGoogle Scholar
  31. 30.
    Bravo, M.G., & Alarcon-Segovia, D.: C-reactive protein in the differential diagnosis between infection and disease reactivation in SLE. J. Rheum. 8: 291, 1981.PubMedGoogle Scholar
  32. 31.
    Deyo, R.A., Pope, R.M., & Persellin, R.H.: Interference by rheumatoid factor with the detection of C-reactive protein by the latex agglutination method. J. Rheum. 7: 279, 1980.PubMedGoogle Scholar
  33. 32.
    Becker, G.J., Waldburger, M., Hughes, G.R.V., & Pepys, M.B.: Value of serum C-reactive protein measurement in the investigation of fever in systemic lupus erythematosus. Ann. of Rheum. Dis. 39: 50, 1980.CrossRefGoogle Scholar
  34. 33.
    Dubois, E.L.: The clinical picture of systemic lupus erythematosus. In Lupus Erythematosus: A Review of the Current Status of Discoid and Systemic Lupus Erythematosus and Their Variants (Ed.) Dubois, E.L. Los Angeles: U. California Press, 1974, pp. 265, 402.Google Scholar
  35. 34.
    Davis, P., Atkins, B., Josse, R.G., & Hughes, G.R.V.: Criteria for classification of SLE. British Medical Journal. iii, 88, 1973.CrossRefGoogle Scholar
  36. 35.
    Matthay, R.A., Schwarz, M.I., Petty, T.L., Stanford, R.E., Gupta, R.C., Sahn, S.A., & Steigerwald, J.C.: Pulmonary manifestations of systemic lupus erythematosus: a reveiw of 12 cases of acute pneumonitis. Medicine. 54: 397, 1975.PubMedCrossRefGoogle Scholar
  37. 36.
    Rajani, K.B., Ashbacher, L.V., & Kinney, T.R.: Pulmonafy haemorrhage in systemic lupus erythematosus. Journal of Paediatrics. 98: 810, 1978.CrossRefGoogle Scholar
  38. 37.
    Rees, A.J., Lockwood, C.M., & Peters, D.K.: Enhanced allergic tissue injury in Goodpasture’s syndrome by intercurrent bacterial infection. British Medical Journal, ii, 7 23, 1977.Google Scholar
  39. 38.
    Bresnihan, B., Hohmeister, R., Cutting, J., Travers, R.L., Waldburger, M., Black, C., Jones, T., & Hughes, G.R.V.: The neuropsychiatry disorder in systemic lupus erythematosus: evidence for both vascular and immune mechanisms. Annals of the Rheumatic Diseases. 38: 301, 1979a.PubMedCrossRefGoogle Scholar
  40. 39.
    Cade, R., Spooner, G., Schlein, E., Pickering, M., deQuisada, A., Holcomb, A., Juncos, L., Richard, G., Shires, D., Levin, D., Hackett, R., Free, J., Hunt, R., & Fregly, M.: Comparison of azathioprine,prednisone, and heparin alone or combined in treating lupus nephritis. Nephron. 16: 37, 1973.CrossRefGoogle Scholar
  41. 40.
    Gurland, B.J., Ganz, V.H., Fleiss, J.L., & Zubin J.: The study of the psychiatric symptoms of systemic lupus erythematosus. Psychosomatic Medicine. 34: 199, 1972.PubMedGoogle Scholar
  42. 41.
    Eaker, M., Hadler, N., Whitaker, J.N., Dunner, D.L., Gerwin, R.D., & Decker, J.L.: Psychopathology in systemic lupus erythematosus: II Relation to clinical observations, corticosteroid administration and cerebrospinal fluid C4. Seminars in Arthritis and Rheumatism. 3: 111, 1973.CrossRefGoogle Scholar
  43. 42.
    Abel, T., Gladman, D.D., & Urowitz, M.B.: Neuropsychiatric lupus. Journal of Rheumatology. 7: 325, 1980.PubMedGoogle Scholar
  44. 43.
    Kassan, S.S. & Kagen, L.J.: Central nervous system lupus erythematosus. Measurement of cerebrospinal fluid cyclic GMP and other clinical markers of disease activity. Arthritis and Rheumatism. 22: 449, 1979.PubMedCrossRefGoogle Scholar
  45. 44.
    Hadler, N.M., Gerwin, R.D., Frank, M.M., Whitaker, J.N. Baker, M., & Decker, J.: Fourth component of complement in the cerebrospinal fluid in systemic lupus erythematosus. Arhtritis and Rheumatism. 16: 507, 1973.CrossRefGoogle Scholar
  46. 45.
    Petz, L.D., Sharp, G.C., Cooper, N.R., & Irwin, W.S.: Serum and cerebrospinal fluid complement and serum autoantibodies in systemic lupus erythematosus. Medicine. 50: 259, 1971.PubMedCrossRefGoogle Scholar
  47. 46.
    Lockshin, M.: Personal communication.Google Scholar
  48. 47.
    Gonzalez-Scarano, F., Lisak, R.P., Bilaniuk, L.T., Zimmerman, R.A., Atkins, P.C., & Zweiman, B.: Cranial computed tomography in the diagnosis of systemic lupus erythematosus. Annals of Neurology. 15: 158, 1979.CrossRefGoogle Scholar

Copyright information

© Martnus Nijhoff Publishing, Boston 1984

Authors and Affiliations

  • Melinda McVicar

There are no affiliations available

Personalised recommendations